AAPG

Ascentage Pharma
AAPG

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$49
65% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Matthew Biegler
0% 1-yr AAPG win rate
4 Dec ‘25 12 days ago
Truist Securities
Truist Securities
Gregory Renza
0% 1-yr AAPG win rate
24 Nov ‘25 22 days ago
BTIG
BTIG
Justin Zelin
0% 1-yr AAPG win rate
10 Nov ‘25 1 month ago
Piper Sandler
Piper Sandler
Biren Amin
0% 1-yr AAPG win rate
5 Nov ‘25 1 month ago